MedPath

Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Completed
Conditions
Polycystic Ovary Syndrome
Interventions
Diagnostic Test: preptin and amylin level
Registration Number
NCT03587415
Lead Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Brief Summary

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Detailed Description

Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (\<25 kg/m2 and ≥25 kg/m2).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria

the patients with PCOS

Exclusion Criteria

Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healty groupspreptin and amylin levelThese women who have reguler menstrual cycle, no akne or hirsutism, we will use their boold samples
Polycyctic ovary sendrome (PCOS)preptin and amylin levelthese women who have PCOS, we will use their blood samples
Primary Outcome Measures
NameTimeMethod
Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patientssix months

Serum Preptin and Amylin Levels will compare between groups

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Recep Tayyip Erdogan University

🇹🇷

Rize, Turkey

© Copyright 2025. All Rights Reserved by MedPath